# Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS

> **NCT04138758** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 42953 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Tiotropium bromide + Olodaterol
- **DRUG:** LABA/ICS

## Key facts

- **NCT ID:** NCT04138758
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-01
- **Primary completion:** 2019-11-04
- **Final completion:** 2019-11-04
- **Target enrollment:** 42953 (ACTUAL)
- **Last updated:** 2021-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04138758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04138758, "Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04138758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*